Medical News

RSS

Cannabis use during pregnancy linked to impaired fetal growth

Cannabidiol (CBD), the component in cannabis often used for therapeutic treatments, is increasingly being used during pregnancy as a means of managing symptoms such as nausea, anxiety and sleep.

6 Feb 2025

Early adversity in firstborns linked to 71% higher risk of mental health issues in younger sibling

Study reveals firstborns facing adversity increase mental health risks in siblings, highlighting the importance of early intervention and family-based support.

6 Feb 2025

New drug delivery system shows promise for treating choriocarcinoma

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.

6 Feb 2025

Study uncovers how UTIs cause painful bladder sensitivity

New insights into what causes the painful and disruptive symptoms of urinary tract infections (UTIs) could offer hope for improved treatment.

6 Feb 2025

Natural immunity to SARS-CoV-2 weakened significantly after Omicron’s emergence

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance protection against reinfection.

6 Feb 2025

Evaluating the usability of AI in emergency medicine to support clinicians

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialed in South Australian hospitals actually has the potential to assist doctors and nurses to rapidly diagnose heart issues in emergency departments.

6 Feb 2025

SAB BIO announces positive topline Phase 1 clinical results with potentially disease-modifying T1D therapy SAB-142

SAB BIO, (“SAB BIO”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D), today announced positive topline data from a Phase 1 trial of SAB-142 in a single-ascending dose among healthy volunteers.

From SAb Biotherapeutics, Inc. 6 Feb 2025

Jumbo phages' protective shield offers clues for fighting antibiotic resistance

Scientists are learning more about how an intriguing type of virus protects itself. Revealing its strategies could boost the fight against antibiotic resistance.

6 Feb 2025

Gyros Protein Technologies introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to support biotherapeutic development

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers, today announced the introduction of its Gyrolab® HEK293 HCP Type SN Kit Reagents and Gyrolab HEK293 HCP Type CL Kit Reagents.

6 Feb 2025

Depression linked to specific changes in eating preferences

Depression affects 280 million people worldwide. The mental illness has been proven to lead to changes in eating behavior.

6 Feb 2025

Advancing living materials with precise control over mechanical properties

Rice University researchers have revealed novel sequence-structure-property relationships for customizing engineered living materials (ELMs), enabling more precise control over their structure and how they respond to deformation forces like stretching or compression.

6 Feb 2025

MaxCyte® acquires SeQure Dx to broaden cell engineering offerings with on-target and off-target editing assessments

MaxCyte, Inc., a leading, cell-engineering focused company providing solutions to advance the discovery, development and commercialization of next-generation cell therapeutics announced today the acquisition of SeQure Dx, a market leader of on-target and off-target editing assessment services for cell and gene therapies.

From MaxCyte, Inc. 6 Feb 2025

Dissatisfaction with facial appearance contributes to Zoom fatigue

Facial appearance dissatisfaction is associated with virtual meeting (VM) fatigue, which prompts the use of impression management behaviors and results in lower intention to adopt VM technologies, according to a study published February 5, 2025, in the open-access journal PLOS One by Chaeyun Lim from Michigan State University, U.S., and colleagues.

6 Feb 2025

Officials seek to dismantle appeals board for Montanans denied public assistance

Montana Gov. Greg Gianforte’s administration is reviving efforts to do away with a panel that hears appeals from people who were denied public assistance to afford basics such as food and health care.

6 Feb 2025

Biden rule cleared hurdles to lifesaving HIV drug, but in Georgia barriers remain

Latonia Wilkins knows she needs to be on PrEP due to her non-monogamous lifestyle. But the 52-year-old Atlanta mother has faced repeated challenges getting the lifesaving drug that can prevent new HIV infections.

6 Feb 2025

Novel AI boosts breast cancer detection in mammograms

The MASAI trial reveals AI in mammography increases cancer detection by 29% and decreases radiologists' workload by 44%, ensuring diagnostic reliability.

6 Feb 2025

Social and health disparities drive brain aging in Latin America

In Brazil, education emerges as the top factor influencing cognitive decline, revealing significant health disparities affecting brain health in Latin America.

6 Feb 2025

$Only a small fraction of people with mental health or substance-use disorders receive effective care$

Medical News

Cannabis use during pregnancy linked to impaired fetal growth

Early adversity in firstborns linked to 71% higher risk of mental health issues in younger sibling

New drug delivery system shows promise for treating choriocarcinoma

Study uncovers how UTIs cause painful bladder sensitivity

Natural immunity to SARS-CoV-2 weakened significantly after Omicron’s emergence

Evaluating the usability of AI in emergency medicine to support clinicians

SAB BIO announces positive topline Phase 1 clinical results with potentially disease-modifying T1D therapy SAB-142

Jumbo phages' protective shield offers clues for fighting antibiotic resistance

Gyros Protein Technologies introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to support biotherapeutic development

Depression linked to specific changes in eating preferences

Advancing living materials with precise control over mechanical properties

MaxCyte® acquires SeQure Dx to broaden cell engineering offerings with on-target and off-target editing assessments

Dissatisfaction with facial appearance contributes to Zoom fatigue

Officials seek to dismantle appeals board for Montanans denied public assistance

Biden rule cleared hurdles to lifesaving HIV drug, but in Georgia barriers remain

Novel AI boosts breast cancer detection in mammograms

Social and health disparities drive brain aging in Latin America

Only a small fraction of people with mental health or substance-use disorders receive effective care

Public health strategies urged to combat early-onset type 2 diabetes in China

Communication between body muscle and pituitary gland may play unexpected role in female fertility

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest News